Genetic Signatures | GSS - Ebitda

Stock Price
0.15
Daily Change
-0.01 -3.33%
Monthly
62.92%
Yearly
-64.63%
Q2 Forecast
0.14

Genetic Signatures reported AUD-7.11M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Avita Medical AUD -9.69M 12.21M Dec/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025